![]() Viracta Therapeutics Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases. | ||
Founding Date | Founding Date 2016 | Founding Date 2004 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Encinitas, US HQ | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US |
Employees | Employees 323% increase | Employees 194362% increase |
Valuation ($) | Valuation ($) 8.7 m | Valuation ($) 515.9 m |
Financial | ||
Net income | Net income ($51.1m) (FY, 2023) | Net income ($153.5m) (FY, 2025) |

UroGen Pharma is a clinical-stage biopharmaceutical company.
View company